Analysis of first and second generation legal highs for synthetic cannabinoids and synthetic stimulants by ultra-performance liquid chromatography and time of flight mass spectrometry

Journal of Analytical Toxicology
Kevin G ShanksAndrea Terrell

Abstract

Various "legal high" products were tested for synthetic cannabinoids and synthetic stimulants to qualitatively determine the active ingredient(s). Ultra-performance liquid chromatography with accurate mass time-of-flight mass spectrometry (UPLC-TOF) was used to monitor the non-biological specimens utilizing a customized panel of 65+ compounds comprised of synthetic cannabinoids, synthetic stimulants and other related drugs. Over the past year, the United States Drug Enforcement Agency has controlled five synthetic cannabinoid compounds (JWH-018, JWH-073, JWH-200, CP-47,497 and CP-47,497-C8) and three synthetic stimulant compounds (3,4-methylenedioxypyrovalerone, mephedrone and methylone) that were previously reported to be detected in these legal high products. Through our analyses of first and second generation products, it was shown that many of these banned substances are no longer used and have been replaced by other derivatives that are federally legal. Since enactment of the federal bans on synthetic cannabinoids and synthetic stimulants, 4.9% of the products analyzed at our facility contained at least one controlled substance. The remaining 95.1% of products contained only uncontrolled drugs. We demonstrate the UPLC-TOF ...Continue Reading

References

Apr 6, 2005·Journal of Analytical Toxicology·Iikka OjanperäMatthias Witt
Jul 12, 2005·Bioorganic & Medicinal Chemistry Letters·John W HuffmanBilly R Martin
Sep 30, 2005·Journal of Medicinal Chemistry·Hongfeng DengAlexandros Makriyannis
Nov 30, 2006·Journal of Analytical Toxicology·Mahmoud A ElSohlyIkhlas A Khan
Oct 2, 2008·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Nahoko UchiyamaYukihiro Goda
Feb 4, 2009·Journal of Mass Spectrometry : JMS·Volker AuwärterNerea Ferreirós
Jul 11, 2009·Forensic Science International : Synergy·Rainer LindigkeitTill Beuerle
Feb 2, 2010·Forensic Science International : Synergy·Nahoko UchiyamaYukihiro Goda
Jun 23, 2010·Toxicology Letters·I VardakouCh Spiliopoulou
Aug 6, 2010·Drug Testing and Analysis·Simon D BrandtJon Cole
Dec 22, 2010·Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists·David M WoodPaul I Dargan
Mar 8, 2011·Legal Medicine·Ruri Kikura-HanajiriYukihiro Goda
Apr 13, 2011·Forensic Science International : Synergy·Ludger ErnstTill Beuerle
Jul 12, 2011·Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists·Joshua SimmonsCarl Skinner
Jul 12, 2011·Clinical Biochemistry·Hannah J PennJames H Nichols
Jul 19, 2011·General Hospital Psychiatry·Thomas M Penders, Richard Gestring
Jan 1, 2010·Journal of Analytical Toxicology·Kristen BaileyJames C Kraner
Aug 10, 2011·Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists·Henry A SpillerJoanne Jansen
Nov 24, 2011·Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology·Jane M Prosser, Lewis S Nelson
Dec 14, 2011·Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology·Brandon J WarrickCynthia Aaron

❮ Previous
Next ❯

Citations

May 15, 2013·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Marek DziadoszJörg Teske
Nov 14, 2012·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Kurt R Lehner, Michael H Baumann
Oct 18, 2012·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Michael H BaumannCharles W Schindler
Aug 24, 2013·Journal of Analytical Toxicology·Robert KronstrandArne Eklund
Jul 11, 2013·Behavioural Pharmacology·Lucas R WattersonMichael Foster Olive
Oct 12, 2013·Life Sciences·Anita H LewinP Anantha Reddy
Jan 16, 2014·Analytical and Bioanalytical Chemistry·Robert KronstrandMartin Josefsson
Nov 16, 2013·Life Sciences·Louis J De FeliceSidney S Negus
May 31, 2014·Journal of Analytical Toxicology·George BehonickChady Meroueh
Aug 5, 2014·Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists·G L BuserR F Leman
Aug 5, 2014·Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists·A SchneirR R Gerona
Nov 21, 2012·Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists·Stephen L ThorntonRoy R Gerona
Mar 12, 2013·Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists·Stephen L ThorntonRoy R Gerona
Jan 13, 2016·Journal of Analytical Toxicology·Kevin G ShanksGeorge Behonick
May 20, 2015·Drug and Alcohol Dependence·Anders Ledberg
Nov 5, 2015·Drug and Alcohol Dependence·Johanna J Nugteren-van LonkhuyzenLaura Hondebrink
May 11, 2016·Legal Medicine·Ladislav HabalaFerdinand Devínsky
Oct 9, 2012·Drug Testing and Analysis·Tim SobolevskyGrigory Rodchenkov
Jun 1, 2013·Journal of Mass Spectrometry : JMS·María IbáñezFélix Hernández
Nov 28, 2014·Drug Testing and Analysis·Tim SobolevskyGrigory Rodchenkov
Dec 4, 2014·Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology·Ayrn D O'ConnorMichael Levine
Jun 29, 2014·Toxicology Letters·Daniel P KatzMuralikrishnan Dhanasekaran
Mar 15, 2015·Journal of Pharmaceutical and Biomedical Analysis·Angelo Antonio D'ArchivioFabrizio Ruggieri
Jan 22, 2013·The International Journal on Drug Policy·Stephen J BrightMonica J Barratt
Nov 28, 2012·European Journal of Pharmacology·Michael H BaumannKurt R Lehner
Aug 7, 2013·Drug and Alcohol Dependence·Karen MiottoChristine Wang
Nov 5, 2014·Journal of Psychoactive Drugs·Patrick S Johnson, Matthew W Johnson
May 18, 2016·Journal of Analytical Toxicology·Jillian R NeifeldThomas Z Bosy
May 31, 2016·Neurotoxicology·Julie A MarusichJenny L Wiley
Sep 18, 2016·Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology·Matilda BäckbergAnders Helander
Sep 30, 2016·Journal of Analytical Toxicology·Damon BorgRichard Stripp
Aug 6, 2016·The Journal of Pharmacology and Experimental Therapeutics·Gregory T CollinsCharles P France

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.